Designs for Massively Parallel Sequencing Approaches to Identify Causal Mutations in Human Immune Disorders

Human Immunological Diseases Unit, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Methods in molecular biology (Clifton, N.J.) (Impact Factor: 1.29). 02/2013; 979:175-87. DOI: 10.1007/978-1-62703-290-2_14
Source: PubMed


Massively parallel sequencing technologies provide new opportunities to discover causal variants and -narrow down candidate genes responsible for human Mendelian disorders. Such information can in turn provide new insights into understanding the basic science behind, as well as improving diagnosis and treatment for, these disorders. In this chapter, we review experimental design and data analysis for sequencing studies of human immune disorders. We discuss optimal experimental designs for sample selection and sequencing approaches, as well as key aspects of data analysis such as filtering and prioritization of identified variants.

8 Reads